Streetbeat News

Earnings

YALA

Yalla Group reported a Q4 adjusted EPS of $0.19, up 58.33% from $0.12 YoY, with sales of $80.92M beating the $79.96M estimate, a 7.74% increase from $75.11M YoY.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:03 pm

HRTG

Heritage Insurance Holdings (NYSE:HRTG) reported Q4 earnings with an EPS of $1.15, beating estimates by 150% and marking a revenue increase of $12.38 million from the previous year. Despite missing EPS estimates last quarter, the company's share price increased by 11% the following day. This performance contrasts with past quarters where EPS and revenue have shown variability.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 8:55 pm

PACK

Ranpak Holdings projects a net revenue growth of 6%-12% and AEBITDA growth of 5%-16% for 2024, with forecasts of $370-$390 million in net revenue and $80-$89 million for AEBITDA, all on a constant currency basis.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:54 pm

HRTG

Heritage Insurance Holdings (HRTG) reported Q4 2023 earnings of $1.15 per share, surpassing the $0.47 estimate by 144.68%, with sales of $186.967M beating the $185.106M estimate, a 7.09% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:51 pm

MTN

Vail Resorts, Inc. (NYSE:MTN) reported Q2 earnings and sales below analyst expectations and lowered its FY2024 guidance due to challenging conditions at its North American resorts. The company cited approximately 42% lower snowfall across its western North American resorts and limited natural snow at its Eastern U.S. resorts as major factors. Despite this, CEO Kirsten Lynch highlighted the strategic business model's resilience and anticipates improved performance in the coming months.

Portfolio Pulse from Erica Kollmann

March 11, 2024 | 8:51 pm

CNC

Centene Corporation is expected to reaffirm its previously issued adjusted EPS guidance for 2024, projecting it to be greater than $6.70, with an estimated EPS of $6.78.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:50 pm

ALTO

Alto Ingredients shares are trading lower following the announcement of disappointing Q4 financial results, which missed market expectations.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:45 pm

OCUL

Ocular Therapeutix shares are trading lower following the announcement of worse-than-expected Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:43 pm

LFMD

LifeMD shares surged following the announcement of their Q4 financial results, which exceeded expectations. Additionally, the company provided positive guidance for the future.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:42 pm

ACAD

Acadia Pharmaceuticals' stock is trading lower following the announcement that its Phase 3 ADVANCE-2 trial of pimavanserin for treating negative symptoms of schizophrenia failed to meet the primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:40 pm